PATIENTS TREATED WITH INSULIN AND SULPHONYLUREA ARE AT INCREASED MORTALITY RISK AS COMPARED WITH THOSE TREATED WITH INSULIN PLUS METFORMIN

AIMS: To investigate the effect of sulphonylurea (SU) treatment on all-cause and cardiovascular mortality as compared with metformin (MET), when used in combination with insulin (INS) in type 2 diabetes. METHODS: All type 2 diabetes patients aged ≥40 years were included at their first prescription o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta Endocrinol (Buchar)
Hauptverfasser: Ioacara, S., Guja, C., Georgescu, O., Martin, S., Sirbu, A., Purcaru, M., Fica, S.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Acta Endocrinologica Foundation 2017
Schlagworte:
Endocrine Care
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6516581/
https://ncbi.nlm.nih.gov/pubmed/31149195
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4183/aeb.2017.329
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge